Acromegaly and colorectal cancer: a comprehensive review of epidemiology, biological mechanisms, and clinical implications.
AuthorsRenehan, Andrew G
O'Halloran, Domhnall J
Potten, Christopher S
O'Dwyer, Sarah T
Shalet, Stephen M
AffiliationDepartment of Surgery, Christie Hospital NHS Trust, Manchester, UK. email@example.com
MetadataShow full item record
AbstractAcromegaly is an endocrine disorder characterised by sustained hypersecretion of growth hormone (GH) with concomitant elevation of insulin-like growth factor (IGF)-I, and is associated with malignancy and premature mortality from cardiovascular and respiratory diseases. In particular, there may be an increased risk of colorectal neoplasia, but the exact extent of this is contentious. Colonoscopy-based studies of adenoma prevalence rates in acromegalic patients are misleading, but population-based studies on colorectal cancer risk are more consistent - a meta-analysis estimated a pooled risk ratio of 2.04 (95 % CI: 1.32, 3.14). Possible mechanisms underlying this increased risk include direct actions as a consequence of elevated levels of circulating GH and IGF-I and/or other perturbations within the IGF system. Other possible mechanisms include altered bile acid secretion, altered cellular immunity, hyperinsulinaemia, shared genetic susceptibility and increased bowel length. However, most explanations only offer indirect evidence, and the expectation of acromegaly as a natural model of colorectal carcinogenesis has not materialised. From a clinical perspective, it seems reasonable to consider a once-only colonoscopic screening at approximately age 55 years, but potential risks and benefits should be balanced.
CitationAcromegaly and colorectal cancer: a comprehensive review of epidemiology, biological mechanisms, and clinical implications., 35 (11-12):712-25 Horm. Metab. Res.
JournalHormone and Metabolic Research
- Detection of colorectal lesions by using autofluorescence colonoscopy in acromegalics and their relation to serum growth hormone and insulin-like growth factor-1 levels.
- Authors: Matyja V, Kos-Kudla B, Foltyn W, Strzelczyk J, Latos W, Marek B, Kajdaniuk D, Karpe J, Ostrowska Z, Sieron-Stoltny K, Sieron A
- Issue date: 2006 Oct
- Risk of colorectal neoplasm in patients with acromegaly and its relationship with serum growth hormone levels.
- Authors: Matano Y, Okada T, Suzuki A, Yoneda T, Takeda Y, Mabuchi H
- Issue date: 2005 May
- Acromegaly, growth hormone and cancer risk.
- Authors: Renehan AG, Brennan BM
- Issue date: 2008 Aug
- Secondary diabetes associated with principal endocrinopathies: the impact of new treatment modalities.
- Authors: Resmini E, Minuto F, Colao A, Ferone D
- Issue date: 2009 Jun
- Cancers associated with acromegaly.
- Authors: Jenkins PJ
- Issue date: 2006